Work

Adjuvant Folfox4 with or without Cetuximab (CTX) in Patients (PTS) with Resected Stage III Colon Cancer (CC): Dfs and OS Results and Subgroup Analyses of the PETACC8 Intergroup Phase III Trial

Year: 2012

Type: article

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)34317-9

Authors: J. Taieb, J. Tabernero, E. Mini, F. Subtil, G. Folprecht, J. Van Laethem, J. Thaler, J.A. Bridgewater, E.J.D. Van Cutsem, P. Rougier, L. Collette, M. Praet, M. Schneider, O. Bouché, C. Lepage, C. Girault, J.F. Emile, P. Laurent-Puig, L. Bedenne

Institutions: Hôpital Européen Georges-Pompidou, Vall d'Hebron Hospital Universitari, University of Florence, Fédération Francophone de Cancérologie Digestive, Technische Universität Dresden, Université Libre de Bruxelles, Erasmus Hospital, Barmherzige Schwestern vom heiligen Kreuz, University College London, Universitair Ziekenhuis Leuven, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, CHU Dijon Bourgogne, Hôpital Ambroise-Paré

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3000612013

FWCI: 1.472

Cites:

Cited by: 13

Related to: 10